Fentanyl Patches Recalled for Mislabeling
Alvogen, Inc., has issued a recall of two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level.
Spravato for Treatment-Resistant Severe Depression (Update)
Esketamine comes with close supervision requirements. 800 clinics have already been approved and dispensed initial applications.
Bleeding Improved with Apixaban versus VKA
Bleeding in patients with nonvalvular atrial fibrillation and coronary syndrome was reduced by apixaban versus vitamin K antagonists.
Kidney Disease Patients May Not Be Getting OACs
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
Keytruda (Pembrolizumab) Issued New Dosage and Indication
The FDA has recently approved new dosage form and two new indications for the drug.
How Pharmacist Provider Status Is Crucial in Fighting the Opioid Epidemic
Progressive Ohio law adds pharmacists as a key patient care team member.
Facebook Takes Steps to Reduce Vaccine Misinformation
Facebook plans to reduce the ranking of groups and pages that spread misinformation about vaccines.
EPA’s New Rules on Drug Disposal Begin in August
Approved regulations allow for some flexibility for drugs that can be redistributed or qualify for manufacturer credit.
Profiles of Four Travel Health Clinics
The strategies these pharmacists followed to succeed.
Pharmacists Must Counsel on Cannabis Interactions
Lack of regulation means protecting public health is pharmacist's duty.
What the World Might Look Like Without Rebates
Providers Advised to Delay Claim Submission until 2019 OPPS Injunction
What you need to know about the 340B litigations.
Prucalopride Approved for Idiopathic Constipation
What you need to know about the serotonin-4 receptor agonist approved for adult patients.
Clinical Pharmacists Are Integral Team Members in PCMHs
Balversa Fast-Tracked for Bladder Cancer
Erdafitinib is first targeted therapy for FGFR3 or FGFR2 genetic alteration.
Flibanserin (Addyi) Issued Label Change
Safety alert issued requiring warning about concurrent alcohol use.
Four Strategies for Reacting to Rude Customers
Diffusing hostility requires empathy, communication, and patience.
Walgreens Ups Competition with New Primary Care Model
Walgreens is partnering with VillageMD to create primary care clinics in Texas
Shingles in Children
HZ in children is uncommon and is 10 times less common in kids who’ve been vaccinated against chickenpox.
NHA Launches Learning Resource for Pharm Techs
Courses can be implemented alongside existing educational programs.
Prices for Generic Drugs Fall by About 9%; Third Decrease in Three Years
The average price of generics is about one-eighteenth the price of the brand product.
Waiving Copays Constitutes Contractual, Legal Violations and Insurance Fraud
Government and PBMs can pursue penalties for noncompliance.
HHS Sec. Praises Community Pharmacies, Outlines Initiatives in NCPA Address
Reimbursement reform tops list of priorities, from DIR fees to rebates.
APhA Conference Coverage: Provider Status Widens, Reimbursements Stall
Key updates from the Seattle, WA, conference in March.
FDA Approves Evenity for Osteoporosis
Evenity (romosozumab-aqqg) has been approved to treat postmenopausal women at high risk of bone fractures.
Soltamox (Tamoxifen Citrate) Issued Labeling Change
Women no longer require nine months of contraception post cessation of the drug.
Resources for Getting Started with Telepharmacy
Like the idea of telpharmacy and not sure where to start?
DOVATO (Dolutegravir and Lamivudine) Approved for HIV-1
First-ever dual-drug, single tablet for HIV offers lighter treatment regimen.
Congressional Testimony Set for PBM CEOs
Advocates are calling for government regulations on PBMs and pharmacy.
FDA Warns on Use of Pre-Owned or Unauthorized Test Strips
Consumers are using test strips that might lead to inaccurate results.
